Curbstone Financial Management Corp’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,687
Closed -$697K 172
2016
Q4
$697K Sell
8,687
-8,687
-50% -$690K 0.44% 65
2016
Q3
$1.39M Sell
17,374
-276
-2% -$22.3K 0.44% 67
2016
Q2
$1.38M Sell
17,650
-200
-1% -$14.3K 0.46% 66
2016
Q1
$982K Buy
17,850
+1,350
+8% +$73.6K 0.33% 90
2015
Q4
$1.02M Buy
16,500
+9,125
+124% +$576K 0.35% 87
2015
Q3
$465K Buy
7,375
+1,375
+23% +$98.1K 0.34% 89
2015
Q2
$438K Sell
6,000
-250
-4% -$18.1K 0.29% 99
2015
Q1
$409K Buy
6,250
+1,825
+41% +$121K 0.28% 98
2014
Q4
$288K Buy
4,425
+925
+26% +$59.6K 0.22% 106
2014
Q3
$210K Hold
3,500
0.17% 132
2014
Q2
$242K Buy
+3,500
New +$227K 0.19% 118

Other funds holding STJ

Curbstone Financial Management Corp's STJ Position: Q1 2017 in Review

Curbstone Financial Management Corp sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,687 shares — an estimated $697K sold.

Curbstone Financial Management Corp first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $1.39M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Curbstone Financial Management Corp reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Curbstone Financial Management Corp sold 8,687 St Jude Medical shares in Q1 2017, an estimated $697K.
  • Curbstone Financial Management Corp first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • Curbstone Financial Management Corp's St Jude Medical position peaked at $1.39M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Curbstone Financial Management Corp's 13F filing for Q1 2017, filed 5 Apr 2017.